Texas HB 1667: Relating to a limit on cost-sharing requirements imposed by a health benefit plan for certain prescription insulin.

Status: Referred to Insurance (as of 2021-03-09)

State: Texas · Session: 87 · Bill: HB 1667

Subjects: DIABETES (S0486), Health--Other Diseases & Medical Conditions (I0383), Insurance--Health & Accident (I0422), MEDICINE & PRESCRIPTION DRUGS (S7338)

Sponsors: Thierry

View Texas HB 1667 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.